Cancer research analysis driven by the biology, not the defaults
Working with a Stanford hematology fellow to analyze flow cytometry data with methods chosen by the science, then presenting the work at NYSDS 2026.
Dr. Gabriel Salzman, a hematology and oncology fellow at Stanford, works with spectral flow cytometry, which measures dozens of markers across millions of cells. Datasets that rich are still usually analyzed with the same manual gating used for classical flow cytometry. Computational methods that explore far more of the data are published, but implementing even one well is real work, and each method sees the data its own way.
Gabriel chose the questions and decided how we would know an answer was right: any population the analysis flagged had to be reproducible by hand in FlowJo from the same raw data. With that rule in place, we directed AI agents to search the literature for suitable clustering and population-discovery approaches, implement and tune each one, and build a dashboard for comparing what they found. Agents also helped train a model that draws gates automatically.
Along the way, a custom view built during the analysis showed that a population of interest was being blurred together with phenotypically distinct cells, something the summary statistics hadn't revealed. That pushed us to broaden the set of methods, and together they surfaced clearer hypothesis candidates than any single one. Early on I steered the agents. Over time Gabriel took the controls, and today he extends the analysis himself.
The work became a poster, “Dynamic AI Agent-Built Visualization Tools for Scientific Inquiry,” at the New York Scientific Data Summit (NYSDS) 2026, which I presented as first author.